Altimmune to Announce Second Quarter 2021 Financial Results on August 11, 2021

Altimmune to Announce Second Quarter 2021 Financial Results on August 11, 2021

GAITHERSBURG, Md., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will report its second quarter 2021 financial results on Wednesday, August 11, 2021.

Altimmune management will host a conference call for investors beginning at 8:30 am E.T. to discuss the second quarter 2021 financial results and provide a business update.

Conference Call Information:

Date:Wednesday, August 11
Time: 8:30 am Eastern Time
Domestic Dial-in: (844) 615-6509
International Dial-in:(918) 922-3148
Conference ID: 9484516
Webcast:https://edge.media-server.com/mmc/p/ne5cqqtf

About Altimmune
Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for obesity and liver diseases. Our pipeline includes next generation peptide therapeutics for obesity, NASH (ALT-801), and chronic hepatitis B (HepTcell™). For more information on Altimmune, please visit www.altimmune.com.

Follow @Altimmune, Inc. on LinkedIn
Follow @AltimmuneInc on Twitter

Investor and Media Contact:
Will Brown
Chief Financial Officer
Phone: 240-654-1450
[email protected]